Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. / Loeschner, Katrin; Hadrup, Niels; Qvortrup, Klaus; Larsen, Agnete; Gao, Xueyun; Vogel, Ulla Birgitte; Mortensen, Alicja; Lam, Henrik Rye; Larsen, Erik Huusfeldt.

In: Particle and Fibre Toxicology, Vol. 8, 01.06.2011, p. 18.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Loeschner, K, Hadrup, N, Qvortrup, K, Larsen, A, Gao, X, Vogel, UB, Mortensen, A, Lam, HR & Larsen, EH 2011, 'Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate', Particle and Fibre Toxicology, vol. 8, pp. 18. https://doi.org/10.1186/1743-8977-8-18

APA

Loeschner, K., Hadrup, N., Qvortrup, K., Larsen, A., Gao, X., Vogel, U. B., Mortensen, A., Lam, H. R., & Larsen, E. H. (2011). Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Particle and Fibre Toxicology, 8, 18. https://doi.org/10.1186/1743-8977-8-18

Vancouver

Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel UB et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Particle and Fibre Toxicology. 2011 Jun 1;8:18. https://doi.org/10.1186/1743-8977-8-18

Author

Loeschner, Katrin ; Hadrup, Niels ; Qvortrup, Klaus ; Larsen, Agnete ; Gao, Xueyun ; Vogel, Ulla Birgitte ; Mortensen, Alicja ; Lam, Henrik Rye ; Larsen, Erik Huusfeldt. / Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. In: Particle and Fibre Toxicology. 2011 ; Vol. 8. pp. 18.

Bibtex

@article{fdb9cee26089417783fe35173611b673,
title = "Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate",
abstract = "Background: The study investigated the distribution of silver after 28 days repeated oral administration of silver nanoparticles (AgNPs) and silver acetate (AgAc) to rats. Oral administration is a relevant route of exposure because of the use of silver nanoparticles in products related to food and food contact materials. Results: AgNPs were synthesized with a size distribution of 14 ± 4 nm in diameter (90% of the nanoparticle volume) and stabilized in aqueous suspension by the polymer polyvinylpyrrolidone (PVP). The AgNPs remained stable throughout the duration of the 28-day oral toxicity study in rats. The organ distribution pattern of silver following administration of AgNPs and AgAc was similar. However the absolute silver concentrations in tissues were lower following oral exposure to AgNPs. This was in agreement with an indication of a higher fecal excretion following administration of AgNPs. Besides the intestinal system, the largest silver concentrations were detected in the liver and kidneys. Silver was also found in the lungs and brain. Autometallographic (AMG) staining revealed a similar cellular localization of silver in ileum, liver, and kidney tissue in rats exposed to AgNPs or AgAc. Using transmission electron microscopy (TEM), nanosized granules were detected in the ileum of animals exposed to AgNPs or AgAc and were mainly located in the basal lamina of the ileal epithelium and in lysosomes of macrophages within the lamina propria. Using energy dispersive x-ray spectroscopy it was shown that the granules in lysosomes consisted of silver, selenium, and sulfur for both AgNP and AgAc exposed rats. The diameter of the deposited granules was in the same size range as that of the administered AgNPs. No silver granules were detected by TEM in the liver. Conclusions: The results of the present study demonstrate that the organ distribution of silver was similar when AgNPs or AgAc were administered orally to rats. The presence of silver granules containing selenium and sulfur in the intestinal wall of rats exposed to either of the silver forms suggests a common mechanism of their formation. Additional studies however, are needed to gain further insight into the underlying mechanisms of the granule formation, and to clarify whether AgNPs dissolve in the gastrointestinal",
keywords = "Acetates, Administration, Oral, Animals, Dose-Response Relationship, Drug, Female, Humans, Ileum, Materials Testing, Metal Nanoparticles, Particle Size, Random Allocation, Rats, Rats, Wistar, Silver, Silver Compounds, Tissue Distribution",
author = "Katrin Loeschner and Niels Hadrup and Klaus Qvortrup and Agnete Larsen and Xueyun Gao and Vogel, {Ulla Birgitte} and Alicja Mortensen and Lam, {Henrik Rye} and Larsen, {Erik Huusfeldt}",
year = "2011",
month = jun,
day = "1",
doi = "10.1186/1743-8977-8-18",
language = "English",
volume = "8",
pages = "18",
journal = "Particle and Fibre Toxicology",
issn = "1743-8977",
publisher = "BioMed Central",

}

RIS

TY - JOUR

T1 - Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate

AU - Loeschner, Katrin

AU - Hadrup, Niels

AU - Qvortrup, Klaus

AU - Larsen, Agnete

AU - Gao, Xueyun

AU - Vogel, Ulla Birgitte

AU - Mortensen, Alicja

AU - Lam, Henrik Rye

AU - Larsen, Erik Huusfeldt

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Background: The study investigated the distribution of silver after 28 days repeated oral administration of silver nanoparticles (AgNPs) and silver acetate (AgAc) to rats. Oral administration is a relevant route of exposure because of the use of silver nanoparticles in products related to food and food contact materials. Results: AgNPs were synthesized with a size distribution of 14 ± 4 nm in diameter (90% of the nanoparticle volume) and stabilized in aqueous suspension by the polymer polyvinylpyrrolidone (PVP). The AgNPs remained stable throughout the duration of the 28-day oral toxicity study in rats. The organ distribution pattern of silver following administration of AgNPs and AgAc was similar. However the absolute silver concentrations in tissues were lower following oral exposure to AgNPs. This was in agreement with an indication of a higher fecal excretion following administration of AgNPs. Besides the intestinal system, the largest silver concentrations were detected in the liver and kidneys. Silver was also found in the lungs and brain. Autometallographic (AMG) staining revealed a similar cellular localization of silver in ileum, liver, and kidney tissue in rats exposed to AgNPs or AgAc. Using transmission electron microscopy (TEM), nanosized granules were detected in the ileum of animals exposed to AgNPs or AgAc and were mainly located in the basal lamina of the ileal epithelium and in lysosomes of macrophages within the lamina propria. Using energy dispersive x-ray spectroscopy it was shown that the granules in lysosomes consisted of silver, selenium, and sulfur for both AgNP and AgAc exposed rats. The diameter of the deposited granules was in the same size range as that of the administered AgNPs. No silver granules were detected by TEM in the liver. Conclusions: The results of the present study demonstrate that the organ distribution of silver was similar when AgNPs or AgAc were administered orally to rats. The presence of silver granules containing selenium and sulfur in the intestinal wall of rats exposed to either of the silver forms suggests a common mechanism of their formation. Additional studies however, are needed to gain further insight into the underlying mechanisms of the granule formation, and to clarify whether AgNPs dissolve in the gastrointestinal

AB - Background: The study investigated the distribution of silver after 28 days repeated oral administration of silver nanoparticles (AgNPs) and silver acetate (AgAc) to rats. Oral administration is a relevant route of exposure because of the use of silver nanoparticles in products related to food and food contact materials. Results: AgNPs were synthesized with a size distribution of 14 ± 4 nm in diameter (90% of the nanoparticle volume) and stabilized in aqueous suspension by the polymer polyvinylpyrrolidone (PVP). The AgNPs remained stable throughout the duration of the 28-day oral toxicity study in rats. The organ distribution pattern of silver following administration of AgNPs and AgAc was similar. However the absolute silver concentrations in tissues were lower following oral exposure to AgNPs. This was in agreement with an indication of a higher fecal excretion following administration of AgNPs. Besides the intestinal system, the largest silver concentrations were detected in the liver and kidneys. Silver was also found in the lungs and brain. Autometallographic (AMG) staining revealed a similar cellular localization of silver in ileum, liver, and kidney tissue in rats exposed to AgNPs or AgAc. Using transmission electron microscopy (TEM), nanosized granules were detected in the ileum of animals exposed to AgNPs or AgAc and were mainly located in the basal lamina of the ileal epithelium and in lysosomes of macrophages within the lamina propria. Using energy dispersive x-ray spectroscopy it was shown that the granules in lysosomes consisted of silver, selenium, and sulfur for both AgNP and AgAc exposed rats. The diameter of the deposited granules was in the same size range as that of the administered AgNPs. No silver granules were detected by TEM in the liver. Conclusions: The results of the present study demonstrate that the organ distribution of silver was similar when AgNPs or AgAc were administered orally to rats. The presence of silver granules containing selenium and sulfur in the intestinal wall of rats exposed to either of the silver forms suggests a common mechanism of their formation. Additional studies however, are needed to gain further insight into the underlying mechanisms of the granule formation, and to clarify whether AgNPs dissolve in the gastrointestinal

KW - Acetates

KW - Administration, Oral

KW - Animals

KW - Dose-Response Relationship, Drug

KW - Female

KW - Humans

KW - Ileum

KW - Materials Testing

KW - Metal Nanoparticles

KW - Particle Size

KW - Random Allocation

KW - Rats

KW - Rats, Wistar

KW - Silver

KW - Silver Compounds

KW - Tissue Distribution

U2 - 10.1186/1743-8977-8-18

DO - 10.1186/1743-8977-8-18

M3 - Journal article

C2 - 21631937

VL - 8

SP - 18

JO - Particle and Fibre Toxicology

JF - Particle and Fibre Toxicology

SN - 1743-8977

ER -

ID: 35165382